Track Enzon Pharmaceuticals's current assets ($230M) with charts, peers, and YoY trends.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
Enzon Pharmaceuticals (ENZN) currently reports a current assets of $230M as of September 2026. That compares with $44M in the prior-year period — up 418.3% year over year. Use the charts on this page to explore Enzon Pharmaceuticals's current assets history and peer comparisons.
Enzon Pharmaceuticals's current assets increased from $44M to $230M — a 418.3% year-over-year increase (period ending September 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Enzon Pharmaceuticals reported $230M in current assets as of September 2026. That compares with $44M in the prior-year period — up 418.3% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current current assets of $230M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Enzon Pharmaceuticals, and consider following ENZN for alerts when major investors trade the stock.
Enzon Pharmaceuticals is classified in the Healthcare sector. On current assets, it currently shows $230M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing ENZN with unrelated industries.